WVE
Wave Life Sciences, Inc.
Key Financials
Revenue
$42.7M
↓ 60.5%
Net Income
$-204378000
↓ 110.7%
Operating Income
$-215383000
↓ 95.1%
EPS (Diluted)
$-1.21
↓ 72.9%
Total Liabilities
$112.3M
↓ 16.7%
Total Assets
$638.5M
↑ 81.3%
Cash & Equivalents
$602.1M
↑ 99.3%
Shareholders' Equity
$518.4M
↑ 147.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| 4 | 10/7/2026 | View on SEC |
| EFFECT | 8/14/2026 | View on SEC |
| 4 | 8/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | WVE |
| Company Name | Wave Life Sciences, Inc. |
| CIK | 1631574 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-949-2900 |